Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
Log in to CareSync Interview Preparation.

Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board intends to award a contract for the provision of Primary Care Enhanced Services, including phlebotomy, treatment rooms, and minor injuries among others, under the Provider Selection Regime. The procurement, classified under the services category, falls within the general-practitioner services industry. Located within the UKF3 region, this direct award is conducted without prior publication of a call for competition due to no suitable tenders in response to an open procedure.
The contract term spans from 1st April 2025 to 31st March 2026, with a financial value of £76,348. Key dates include the notice publication on 28th August 2025 and a standstill period allowing provider representations until 9th September 2025. The current procurement stage is the award phase, although the contract has not been formally awarded yet.
This tender offers substantial opportunities for businesses operating within the healthcare sector, particularly those with experience in delivering enhanced primary care services. Small and medium-sized enterprises (SMEs), such as those that focus on community health provision, are well-positioned to compete, especially if they can demonstrate quality and innovation, value, service sustainability, and the ability to reduce health inequalities. By engaging in this procurement process, businesses can potentially expand their service offerings within the public healthcare system, enhancing their reputation and securing steady revenue through NHS partnerships.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing - Ambulatory ECG (South West locality only) The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS76,348 The provider is an existing provider and the services are existing services.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us